In addition, BRCA2 acts as a tumor suppressor in mitotic HR, and HSF2BP can bind to BRCA2 and mediate its recombination localization, thereby promoting cancer development by interfering with the mitotic HR pathway [15]. The gene discussed is HSF2BP; the disease is cancer.